SITAGLIPTIN-METFORMIN
SITAGLIPTIN-METFORMIN
Approved
DIN Number
02529157
Drug Class
Human
Market Date
Feb 6, 2023
Company
HC
sivem pharmaceuticals ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02529157
AIG Number0252656001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BD07 METFORMIN AND SITAGLIPTIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.05
Health Canada Classification
ACTIVE INGREDIENTS (2)
METFORMIN HYDROCHLORIDEActive
Strength: 500 MG
Monograph: METFORMIN HYDROCHLORIDE
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)Active
Strength: 50 MG
Monograph: SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)